ANILAZINE
UNII C6E8Y03ZJN

Substance Identification & Data

This profile provides standardized clinical and technical data for Anilazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C6E8Y03ZJN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 101-05-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C6E8Y03ZJN

CAS Registry Number

101-05-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANILAZINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C9H5Cl3N4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IMHBYKMAHXWHRP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

7541

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nc(Cl)nc(n1)Cl)Nc2c(Cl)cccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anilazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.